Yilmaz, Y. Et Al. 2009. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Medical Science Monitor , vol.15 .

Yilmaz, Y., Dolar, E., Ulukaya, E., Akgoz, S., Keskin, M., Kiyici, M., ... Yerci, O.(2009). Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Medical Science Monitor , vol.15.

Yilmaz, YUSUF Et Al. "Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C," Medical Science Monitor , vol.15, 2009

Yilmaz, YUSUF Et Al. "Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C." Medical Science Monitor , vol.15, 2009

Yilmaz, Y. Et Al. (2009) . "Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C." Medical Science Monitor , vol.15.

@article{article, author={YUSUF YILMAZ Et Al. }, title={Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C}, journal={Medical Science Monitor}, year=2009}